Nanowear announces fda 510(k) clearance for ai-enabled continuous blood pressure monitoring and hypertension diagnostic management: simplesense-bp

New york--(business wire)--nanowear, a leader in healthcare-at-home remote diagnostics, announced that its nanotechnology-enabled wearable and software platform, simplesensetm, has received fda 510(k) clearance for a novel ai-enabled software-as-a-medical device (samd). as the first non-invasive, cuffless, continuous blood pressure monitor, and diagnostic, simplesense-bp provides a transformational tool in clinical diagnostic management of hypertension and is additive to the wearable platform's.
BP Ratings Summary
BP Quant Ranking